Background pattern of a brain with neural connections
Veronique Daniels

Veronique Daniels

Project Manager

KU Leuven

Veronique is an innovation manager at KU Leuven, covering the areas of molecular imaging and Parkinson’s disease. Veronique has a key role in valorising the research results and connecting with relevant industry partners, other academic groups and patient organisations. Additionally, she is managing the Leuven Viral Vector Core. Veronique completed her PhD in Biomedical sciences in the lab of Prof. Baekelandt. She pursued her research career as a post-doctoral scientists at UCB (Belgium) working on in vitro pharmacology and assay development. From 2015 to 2017, Veronique was employed as a Study Director at Toxikon Europe (Belgium) where she was devoted to consulting and management of extractables and leachables studies.

Recent ASAP Preprints & Published Papers

Novel green fluorescent polyamines to analyze ATP13A2 and ATP13A3 activity in the mammalian polyamine transport system

Cells acquire polyamines putrescine (PUT), spermidine (SPD) and spermine (SPM) via the complementary actions of polyamine uptake and synthesis pathways. The endosomal P5B-type ATPases ATP13A2 and ATP13A3 emerge as major determinants of mammalian polyamine uptake. Our biochemical evidence shows that fluorescently labeled polyamines are genuine substrates of ATP13A2. They can be used to measure polyamine uptake in ATP13A2- and ATP13A3-dependent cell models resembling radiolabeled polyamine uptake. We further report that ATP13A3 enables faster and stronger cellular polyamine uptake than does ATP13A2. We also compared the uptake of new green fluorescent PUT, SPD and SPM analogs using different coupling strategies (amide, triazole or isothiocyanate) and fluorophores (symmetrical BODIPY, BODIPY-FL and FITC). ATP13A2 promotes the uptake of various SPD and SPM analogs, whereas ATP13A3 mainly stimulates the uptake of PUT and SPD conjugates. However, the polyamine linker and coupling position on the fluorophore impacts the transport capacity, whereas replacing the fluorophore affects polyamine selectivity. The highest uptake in ATP13A2 or ATP13A3 cells is observed with BODIPY-FL-amide conjugated to SPD, whereas BODIPY-PUT analogs are specifically taken up via ATP13A3. We found that P5B-type ATPase isoforms transport fluorescently labeled polyamine analogs with a distinct structure–activity relationship (SAR), suggesting that isoform-specific polyamine probes can be designed.

Our Research Teams

Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.